- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 3.36M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $289K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.84M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.75M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.82M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.13M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $14.77M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $16.24M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.62M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.43M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.99M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.94M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.1M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.41M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.12M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $19.71M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.22 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$10.27 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.92M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.38M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.95M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$8.32M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.14M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$8.68M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $501K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $724K |